TEVA 7166 (Celecoxib 200 mg)
Pill with imprint TEVA 7166 is White & Yellow, Capsule-shape and has been identified as Celecoxib 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Celecoxib is used in the treatment of ankylosing spondylitis; osteoarthritis; familial adenomatous polyposis; juvenile rheumatoid arthritis; migraine and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7166
Celecoxib
- Imprint
- TEVA 7166
- Strength
- 200 mg
- Color
- White & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cox-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7166 | Teva Pharmaceuticals USA, Inc. |
| 42291-0194 | AvKare, Inc. |
| 68084-0976 | Amerisource Health Services |
More about celecoxib
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 224 Reviews
- Drug class: cox-2 inhibitors
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.